Drug delivery control method and apparatus for skin administration
Patent Information
- Application Number
- MYPI2025000666
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-07-27
- Filing Date
- 2023-05-05
- Publication Date
- 2024-01-27
AI Technical Summary
The drug delivery efficiency in the existing technology is low, especially oral administration, injection, patching, fumigation and other methods of drug absorption, making it difficult to directly act on the lesion location.
Through the temperature and pressure coupling control method, the drug delivery control parameters are determined to form a pressure difference on the skin to achieve non-invasive drug delivery through the skin. The pressure difference and temperature difference are used to form a sealed area in the drug delivery device for drug penetration.
The drug delivery efficiency is improved, ensuring that the drug can directly penetrate the skin and reach the lesion location, and solves the problem of low drug delivery efficiency in the existing technology.
Smart Images

Figure PI2025000666_DRAWING_001 
Figure PI2025000666_DRAWING_002 
Figure PI2025000666_DRAWING_003
Abstract
Description
Drug delivery control method and device for skin drug delivery
[0001] This application claims priority to the Chinese invention patent application with application number 2022108911799, entitled “Drug administration control method and device for skin drug delivery”, filed with the China Intellectual Property Office on July 27, 2022. The entire disclosure of the application is incorporated herein by reference. Technical Field
[0002] The present application relates to the field of intelligent medical treatment, and more specifically, to a drug delivery control method and device for transdermal drug delivery. Background Art
[0003] Drug therapy is a commonly used means of treatment. The absorption effect of the drug has a great influence on the effect of the treatment. In the existing technology, drug therapy is carried out through administration methods including oral administration, injection, patch application and fumigation. Among the above-mentioned administration methods, oral administration has a drug administration efficiency affected by digestive function. The invasive administration process has high requirements for drugs, and neither intramuscular injection nor intravenous injection directly acts on the lesion site. The effective drug components of the patch application and fumigation are difficult to be fully absorbed, resulting in low drug administration efficiency.
[0004] Therefore, the drug administration in the prior art has the problem of low drug administration efficiency.
[0005] Summary of the Invention
[0006] The main purpose of the present application is to provide a drug delivery control method and device for skin drug delivery, so as to solve the technical problem of low drug delivery efficiency in the prior art and achieve the technical effect of improving drug delivery efficiency.
[0007] To achieve the above objectives, in a first aspect of the present application, a drug administration control method for transdermal drug delivery is proposed, which is used to control the drug to be administered non-invasively through the skin through temperature and pressure coupling control to achieve drug administration therapy. The drug administration control method comprises:
[0008] determining drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, one of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter;
[0009] The pressure difference of the drug delivery through the skin is controlled by the pressure control parameter and the temperature control parameter, and the pressure difference is the pressure difference of the drug delivery through the skin.
[0010] In some embodiments of the present application, the drug administration control method is applied to a drug administration device provided with an auxiliary drug administration unit and a direct drug administration unit, and the drug administration control method includes:
[0011] Identifying the pressure control parameter to obtain a first pressure control parameter and a second pressure control parameter;
[0012] controlling the auxiliary drug delivery unit to generate a first pressure according to the first pressure control parameter, wherein the first pressure is used to fix the drug delivery device to the skin and form a closed drug delivery area;
[0013] controlling the direct drug delivery unit to generate a second pressure according to the second pressure control parameter, wherein the first pressure is less than the second pressure; and
[0014] The direct drug delivery unit is controlled according to the temperature control parameter to generate a drug delivery temperature. The drug delivery temperature, the first pressure, and the second pressure form a pressure difference for skin drug delivery in the closed drug delivery area.
[0015] In some embodiments of the present application, the drug administration temperature, the first pressure, and the second pressure forming a pressure difference for skin drug administration in the closed drug administration area include:
[0016] Acquiring medication pressure difference data, wherein the medication pressure difference data is data used to represent the pressure difference in the enclosed medication area;
[0017] Determine whether the drug administration pressure difference data meets the preset drug administration pressure difference range,
[0018] If not, generating an updated pressure control parameter, wherein the first pressure data and the second pressure data are updated according to the updated pressure control parameter until the medication pressure difference data meets the preset medication pressure difference range;
[0019] If satisfied, the drug is administered in the enclosed administration area.
[0020] In some embodiments of the present application, the drug administration temperature, the first pressure, and the second pressure forming a pressure difference for skin drug administration in the closed drug administration area include:
[0021] Acquiring medication pressure difference data, wherein the medication pressure difference data is data used to represent the pressure difference in a closed area;
[0022] Determine whether the drug administration pressure difference data meets the preset drug administration pressure difference range;
[0023] If not, generating an updated temperature control parameter, wherein the updated temperature is determined according to the temperature control parameter until the medication pressure difference satisfies a preset medication pressure difference range;
[0024] If satisfied, administer the medication in a confined administration area.
[0025] In some embodiments of the present application, determining drug delivery control parameters for skin drug delivery includes:
[0026] determining first control parameter change data, wherein the first control parameter change data is parameter change data for representing a first control parameter; and
[0027] The parameter change of the second control parameter is determined according to the first control parameter change data to obtain second control parameter change data.
[0028] In some embodiments of the present application, determining drug delivery control parameters for skin drug delivery includes:
[0029] Determining drug administration characteristic data, wherein the drug administration characteristic data includes drug characteristic data and drug administration location characteristic data;
[0030] matching a medication control model corresponding to the drug characteristic data and the medication location characteristic data in a preset medication database, wherein the medication control model is a model for representing changes in the first control parameter and the second control parameter during medication time; and
[0031] Changes in the first control parameter and the second control parameter are determined according to a drug administration control model.
[0032] In some embodiments of the present application, controlling the pressure difference of skin drug delivery by the pressure control parameter and the temperature control parameter includes:
[0033] The pressure difference for skin administration is determined based on the first pressure, the second pressure and the administration temperature, wherein the expression for the administration pressure difference is: ci = f(va, vb, T), wherein ci is the pressure difference, va is the first pressure in the direct administration unit, vb is the second pressure in the auxiliary administration unit, and T is the administration temperature of the direct administration unit.
[0034] In some embodiments of the present application, a temperature detection element is provided in the drug delivery device for detecting the temperature in the drug delivery area to achieve control of matching drug delivery. The drug delivery control method includes:
[0035] Acquiring medication temperature detection data, wherein the medication temperature detection data is temperature data within the medication area;
[0036] The drug administration detection data is judged based on a preset temperature range,
[0037] If the detected temperature does not meet the preset temperature range, a temperature control parameter is generated. According to a second aspect of the present application, a drug administration control device for skin drug administration is provided, which is used to control the drug to be administered non-invasively through the skin through temperature and pressure coupling control to achieve drug administration treatment, and the drug administration control device includes:
[0038] a parameter determination module, configured to determine drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, a first of the first control parameter and the second control parameter being a pressure control parameter, and the other of the first control parameter and the second control parameter being a temperature control parameter;
[0039] The pressure difference module is used to control the pressure difference of skin drug delivery through the pressure control parameter and the temperature control parameter, wherein the pressure difference is the pressure difference for drug delivery through the skin.
[0040] In some embodiments of the present application, the drug administration control device is applied to a drug administration device provided with an auxiliary drug administration unit and a direct drug administration unit, and the drug administration control device includes:
[0041] an identification module, configured to identify the pressure control parameter to obtain a first pressure control parameter and a second pressure control parameter;
[0042] a first pressure module, configured to control the auxiliary drug delivery unit to generate a first pressure according to the first pressure control parameter, wherein the first pressure is used to fix the drug delivery device to the skin and form a closed drug delivery area;
[0043] a second pressure module, configured to control the direct drug delivery unit to generate a second pressure according to the second pressure control parameter, wherein the first pressure is less than the second pressure;
[0044] a temperature control module, configured to control the direct drug delivery unit to generate a drug delivery temperature according to the temperature control parameter;
[0045] The pressure difference drug administration module is used to form a pressure difference for skin drug administration in the closed drug administration area according to the drug administration temperature, the first pressure and the second pressure.
[0046] In some embodiments of the present application, the pressure difference drug delivery module includes:
[0047] a pressure difference acquisition module, configured to acquire medication pressure difference data, wherein the medication pressure difference data is data representing the pressure difference within the enclosed medication area;
[0048] The pressure difference judgment module is used to judge whether the drug administration pressure difference data meets the preset drug administration pressure difference range,
[0049] If the pressure difference control module does not meet the requirements, it generates an updated pressure control parameter, wherein the first pressure data and the second pressure data are updated according to the updated pressure control parameter until the medication pressure difference data meets the preset medication pressure difference range; and
[0050] If satisfied, the drug is administered in the enclosed administration area.
[0051] In some embodiments of the present application, the pressure difference drug delivery module includes:
[0052] a pressure difference acquisition module, configured to acquire medication pressure difference data, wherein the medication pressure difference data is data representing the pressure difference within the enclosed medication area;
[0053] The pressure difference judgment module is used to judge whether the drug administration pressure difference data meets the preset drug administration pressure difference range,
[0054] The temperature control module generates an updated temperature control parameter if the condition is not met, wherein the updated temperature is determined according to the temperature control parameter until the medication pressure difference meets the preset medication pressure difference range;
[0055] If satisfied, administer the medication in a confined administration area.
[0056] In some embodiments of the present application, the parameter determination module includes:
[0057] a first control parameter module, configured to determine first control parameter change data, wherein the first control parameter change data is parameter change data representing the first control parameter; and
[0058] The second control parameter module is configured to determine a parameter change of the second control parameter according to the first control parameter change data to obtain second control parameter change data.
[0059] In some embodiments of the present application, the parameter determination module includes:
[0060] a drug administration data acquisition module, configured to determine drug administration characteristic data, wherein the drug administration characteristic data includes drug characteristic data and drug administration location characteristic data;
[0061] a model matching module, configured to match a medication control model corresponding to the drug characteristic data and the medication location characteristic data in a preset medication database, wherein the medication control model is a model for representing changes in the first control parameter and the second control parameter during medication time; and
[0062] The drug administration parameter determination module is used to determine the changes of the first control parameter and the second control parameter according to the drug administration control model.
[0063] In some embodiments of the present application,
[0064] The pressure difference module determines the pressure difference of skin drug delivery based on the first pressure, the second pressure and the drug delivery temperature, wherein the expression of the drug delivery pressure difference is: ci = f(va, vb, T), wherein ci is the pressure difference, va is the first pressure in the direct drug delivery unit, vb is the second pressure of the auxiliary drug delivery unit, and T is the drug delivery temperature of the direct drug delivery unit.
[0065] In some embodiments of the present application, a temperature detection element is provided in the drug delivery device for detecting the temperature in the drug delivery area to achieve control of matching drug delivery. The drug delivery control device includes:
[0066] A drug administration temperature detection module, configured to obtain drug administration temperature detection data, wherein the drug administration temperature detection data is temperature data within the drug administration area;
[0067] The drug administration temperature judgment module is used to judge the drug administration detection data based on a preset temperature range.
[0068] The drug administration temperature control module generates a temperature control parameter if the detected temperature does not meet the preset temperature range.
[0069] According to a third aspect of the present application, a drug delivery device for transdermal drug delivery is provided, which is used to control the drug delivery through the skin in a non-invasive manner through temperature and pressure coupling control to achieve drug delivery therapy, wherein the drug delivery device is fixed to the skin and comprises:
[0070] The pressure component and the temperature component control the pressure and temperature of the skin drug delivery to form a pressure difference for the skin drug delivery, and the pressure difference is the pressure difference for drug delivery through the skin.
[0071] In some embodiments of the present application, the drug delivery device includes an auxiliary drug delivery component and a direct drug delivery component, wherein:
[0072] The pressure assembly includes a first pressure assembly and a second pressure assembly;
[0073] The auxiliary drug delivery component is provided with the first pressure component, which generates a first pressure, and the first pressure is a pressure used to fix the drug delivery device on the skin and form a closed drug delivery area;
[0074] The direct drug delivery component is provided with the second pressure component and the temperature component. The second pressure component generates a second pressure. The temperature component controls the temperature in the closed drug delivery area. The first pressure, the second pressure and the temperature control the pressure difference for skin drug delivery in the closed drug delivery area. The pressure difference is the pressure difference for drug delivery through the skin.
[0075] In some optional embodiments of the present application, the drug delivery device further includes a drug delivery control device, wherein the drug delivery control device includes:
[0076] a parameter determination module, configured to determine drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, a first of the first control parameter and the second control parameter being a pressure control parameter, and the other of the first control parameter and the second control parameter being a temperature control parameter; and
[0077] The pressure difference module is used to control the pressure difference of skin drug delivery through the pressure control parameter and the temperature control parameter, wherein the pressure difference is the pressure difference for drug delivery through the skin.
[0078] According to a fourth aspect of the present application, a computer-readable storage medium is provided, wherein the computer-readable storage medium stores computer instructions, and the computer instructions are used to enable the computer to execute the above-mentioned drug administration control method for skin drug administration.
[0079] The technical solutions provided by the embodiments of the present application may have the following beneficial effects:
[0080] In the present application, by coupling temperature and pressure, the drug is controlled to be administered non-invasively through the skin to achieve drug administration therapy. By determining the drug administration control parameters for skin drug administration, the drug administration control parameters include pressure control parameters and temperature control parameters. The pressure difference of drug administration at the skin drug administration position is controlled by coupling the pressure control parameters and the temperature control parameters to form a pressure difference for drug administration through the skin. By setting the pressure and temperature to form a pressure difference at the skin drug administration position to form a non-invasive drug administration through the skin, the problem of low drug administration efficiency in the prior art is solved, and the technical effect of improving drug administration efficiency is achieved. BRIEF DESCRIPTION OF THE DRAWINGS
[0081] The drawings that constitute part of this application are used to provide a further understanding of this application and make other features, objects and advantages of this application more apparent. The illustrative embodiment drawings of this application and their descriptions are used to explain this application and do not constitute an improper limitation of this application. In the drawings:
[0082] FIG1 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application;
[0083] FIG2 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application;
[0084] FIG3 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application;
[0085] FIG4 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application;
[0086] FIG5 is a structural diagram of a drug delivery control device for transdermal drug delivery provided by the present application;
[0087] FIG6 is a structural diagram of another drug delivery control device for transdermal drug delivery provided by the present application;
[0088] 7 and 8 are structural diagrams of a drug delivery device for skin drug delivery provided by the present application. DETAILED DESCRIPTION
[0089] In order to enable those skilled in the art to better understand the present invention, the following will clearly and completely describe the technical solutions in the embodiments of the present invention in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in this field without making creative efforts should fall within the scope of protection of this application.
[0090] It should be noted that the terms "first", "second", etc. in the specification and claims of the present application and the above-mentioned drawings are used to distinguish similar objects and are not necessarily used to describe a specific order or sequential order. It should be understood that the data used in this way can be interchanged where appropriate, so that the embodiments of the present application described here. In addition, the terms "including" and "having" and any of their variations are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.
[0091] In this application, terms such as "upper," "lower," "left," "right," "front," "back," "top," "bottom," "inner," "outer," "center," "vertical," "horizontal," "transverse," and "longitudinal" indicate positions or locations based on the positions or locations shown in the accompanying drawings. These terms are primarily intended to better describe this application and its embodiments and are not intended to limit the devices, elements, or components indicated to having a specific orientation, or to being constructed or operated in a specific orientation.
[0092] Furthermore, some of the above terms may be used to express other meanings besides indicating a position or location. For example, the term "on" may also be used to indicate a dependency or connection in certain circumstances. Those skilled in the art will understand the specific meanings of these terms in this application based on the specific circumstances.
[0093] Furthermore, the terms "installed," "disposed," "provided with," "connected," "connected," and "socketed" should be interpreted broadly. For example, "connected" can mean a fixed connection, a removable connection, or an integral structure; it can be a mechanical connection or an electrical connection; it can be a direct connection, an indirect connection through an intermediary, or an internal communication between two devices, elements, or components. Those skilled in the art will understand the specific meanings of these terms in this application based on the specific circumstances.
[0094] The present application provides a drug administration control method for skin drug administration, which controls the drug to be administered non-invasively through the skin through temperature and pressure coupling control to achieve drug administration treatment. The drug administration control method is applied to a drug administration device provided with a temperature control module and a pressure control module. The drug administration device is connected to the skin drug administration position. The temperature control module and the pressure control module control the pressure and temperature in the drug administration area formed by the drug administration device and the skin to form a pressure difference for drug administration through the skin, so that the drug is administered through the skin. In an embodiment of the present application, by forming a pressure difference in the drug administration area, the pressure difference provides power for the drug molecules to penetrate the skin, and the pressure difference forms the power for the drug molecules to reach the direct drug administration position after penetrating the skin. For example, when performing drug administration treatment for lung disease, drug administration control is performed on the back, and the drug components enter the body through the drug administration area on the back. By controlling the pressure difference in the drug administration area, the pressure difference provides power for the drug components to pass through the skin on the back, and provides power for the drug components to reach the lungs after penetrating the skin.
[0095] FIG1 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application. As shown in FIG1 , the method includes the following steps:
[0096] S101: Determine drug delivery control parameters for skin drug delivery;
[0097] The control parameters include a first control parameter and a second control parameter, one of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter.
[0098] FIG2 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application. As shown in FIG2 , the method includes the following steps:
[0099] S201: Determine drug administration characteristic data;
[0100] The drug administration characteristic data includes drug characteristic data and drug administration location characteristic data. The drug characteristic data is characteristic data used to represent the drug to be administered, including data used to represent the drug components and drug structure. For example, the components of the drug to be administered can be single-component or multi-component drugs, and the structure of the drug to be administered can be solid drugs, liquid drugs or gaseous drugs; the drug administration location characteristic data is used to represent the location where the drug administration treatment is performed, including the drug administration skin location that is in direct contact with the drug administration device and the location corresponding to the disease target of the drug administration treatment. For example, the drug administration skin location that is in direct contact with the drug administration device can be the lung shu point on the back, and the drug administration skin location that is in direct contact with the drug administration device can be the facial location; the location corresponding to the disease target of the drug administration treatment can be the lung location corresponding to lung disease, and the location corresponding to the disease target of the drug administration treatment can be the facial epidermis or facial dermis.
[0101] S202: Matching a medication control model corresponding to the medication characteristic data and the medication location characteristic data in a preset medication database;
[0102] The drug administration control model is a model for representing the changes of the first control parameter and the second control parameter during the drug administration time. The drug administration control model is a model for controlling the changes of pressure and temperature in the drug administration area over time within a preset drug administration time period. It is used to guide the changes of temperature and pressure over time during the drug administration time period, and different drugs and different drug administration positions correspond to different drug administration temperatures and drug administration pressures. For example, when administering drug administration treatment for lung diseases, component drug A is administered on the back, the first drug administration pressure is VA1min~VA1max, the second drug administration pressure is VA2min~VA2max, the temperature is T1min~T1max, and a closed drug administration area is formed on the back, and the pressure difference in the closed drug administration area is ΔVAmin~ΔVAmax. When performing facial beauty treatment, beauty product B is administered on the face, the first drug administration pressure is VB1min~VB1max, the second drug administration pressure is VB2min~VB2max, and the temperature is T2min~T2max. A closed dosing area is formed on the back and the pressure difference within the closed dosing area is ΔVBmin~ΔVBmax. Due to the different skin tolerance levels of the back skin and the facial skin, the dosing temperature and pressure corresponding to different drugs and different dosing positions are different. The dosing temperature and pressure at the corresponding dosing position are adjusted according to different drugs and different dosing positions.
[0103] S203: Determine changes in the first control parameter and the second control parameter according to the drug administration control model.
[0104] The first control parameter and the second control parameter are controlled according to the drug administration control model, and the temperature parameter and the pressure parameter during the drug administration process are controlled to achieve control of the drug administration pressure difference.
[0105] In an optional embodiment of the present application, a method for controlling during a drug administration process is provided, the method comprising the following steps: obtaining a drug administration instruction, identifying the drug administration instruction, obtaining drug administration characteristic data, matching a drug administration control model corresponding to the drug administration characteristic data in a preset drug administration database, and when it is detected that the drug administration device is in contact with the skin, controlling the drug administration device to change the pressure and temperature according to the above-mentioned drug administration control model, detecting the pressure difference in the drug administration area by a pressure difference detection element provided in the drug administration device, and judging whether the pressure difference data satisfies the drug administration pressure difference range corresponding to the above-mentioned drug administration control model. If not, the drug administration control model generates a pressure adjustment parameter and a temperature adjustment parameter according to the currently detected pressure difference data, the pressure module adjusts the pressure according to the pressure adjustment parameter, and the temperature module adjusts the temperature according to the temperature adjustment parameter. By monitoring the pressure difference during the drug administration process and performing feedback adjustment based on the pressure difference data obtained by monitoring according to the drug administration control model, the temperature difference data in the drug administration area is controlled to be within the preset drug administration pressure difference range, and skin drug administration is performed.
[0106] In an embodiment of the present application, feedback control is performed during the drug administration process by setting a pressure difference detection element in the drug administration device, and the detected pressure difference data is compared with a preset drug administration pressure difference range, so that the temperature and pressure are controlled during the drug administration process and the drug administration pressure difference is controlled. The pressure difference forms the driving force for the drug to penetrate the skin and act at the location of the disease, thereby improving the drug administration efficiency.
[0107] S102: Control the pressure difference of the drug delivery through the skin by means of a pressure control parameter and a temperature control parameter. The pressure difference is the pressure difference for drug delivery through the skin.
[0108] In another optional embodiment of the present application, a drug administration control method for transdermal drug delivery is provided. The drug administration control method is applied to a drug delivery device provided with an auxiliary drug delivery unit and a direct drug delivery unit. FIG3 is a flow chart of a drug administration control method for transdermal drug delivery provided by the present application. As shown in FIG2 , the method includes the following steps:
[0109] S301: Identify the pressure control parameter to obtain a first pressure control parameter and a second pressure control parameter;
[0110] Both the auxiliary dosing unit and the direct dosing unit are provided with a pressure module, and the pressure needs to be controlled by a pressure control parameter. One of the first pressure control parameter and the second pressure control parameter is a pressure control parameter used to control the auxiliary dosing unit, and the other of the first pressure control parameter and the second pressure control parameter is a pressure control parameter used to control the direct dosing unit.
[0111] S302: Controlling the auxiliary drug delivery unit to generate a first pressure according to a first pressure control parameter, wherein the first pressure is used to fix the drug delivery device to the skin and form a closed drug delivery area;
[0112] The first pressure control parameter is a parameter for controlling the pressure of the auxiliary dosing unit. Air is pumped out through a pressure device arranged in the auxiliary dosing unit, such as a vacuum assembly of the auxiliary dosing unit. The dosing device is fixed to the skin dosing position through the vacuum process, and a closed dosing area is formed at the dosing position.
[0113] S303: Controlling the direct drug delivery unit to generate a second pressure according to a second pressure control parameter, wherein the first drug delivery pressure is lower than the second drug delivery pressure;
[0114] The second pressure control parameter is a parameter for controlling the pressure change of the direct drug delivery unit. The second pressure is generated by a pressure device arranged in the direct drug delivery unit, such as by an inflation component in the direct drug delivery unit. The first pressure is set to be lower than the second pressure so that the drug delivery device is fixed to the skin by the first pressure and the drug delivery device forms a closed drug delivery area on the skin. The difference between the first pressure and the second pressure forms a pressure difference in the closed drug delivery area, which is used to provide a pressure difference for the drug to penetrate the skin.
[0115] In another optional embodiment of the present application, the drug-carrying module is arranged in the direct drug delivery unit. If the drug to be delivered is a solid or liquid structure, the solid drug or liquid drug is arranged on the drug-carrying module in the direct drug delivery unit, and the pressure module in the direct drug delivery unit is controlled to generate a second pressure. The first pressure formed by the auxiliary drug delivery unit, the second pressure formed by the direct drug delivery unit, and the drug delivery temperature form a drug delivery pressure difference, and the solid drug or liquid drug component penetrates the skin for delivery; if the drug to be delivered is a gas structure, the drug gas to be delivered and the pressure module that controls the pressure by inflation generate a second pressure. The first pressure formed by the auxiliary drug delivery unit, the second pressure formed by the direct drug delivery unit, and the drug delivery temperature form a drug delivery pressure difference, and the drug component penetrates the skin for delivery.
[0116] S304: Control the direct drug delivery unit to generate a drug delivery temperature according to the temperature control parameter. The drug delivery temperature, the first pressure, and the second pressure form a pressure difference for skin drug delivery in the closed drug delivery area.
[0117] A temperature control module, such as a heating component, is provided in the direct medication unit to control the temperature increase in the sealed medication area, and to work together with the first pressure and the second pressure to form a medication pressure difference in the sealed medication area.
[0118] In another optional embodiment of the present application, a method for forming a pressure difference for skin drug delivery in a closed drug delivery area is provided.
[0119] Acquiring medication pressure difference data, wherein the medication pressure difference data is data used to represent the pressure difference in a closed medication area;
[0120] Determine whether the drug administration pressure difference data meets the preset drug administration pressure difference range,
[0121] If not, generating an updated pressure control parameter, wherein the first pressure data and the second pressure data are updated according to the updated pressure control parameter until the medication pressure difference data satisfies a preset medication pressure difference range;
[0122] If satisfied, administer the medication in a confined administration area.
[0123] In another optional embodiment of the present application, a method for controlling the medication pressure difference within a sealed medication area by temperature control is also provided, the method comprising:
[0124] Acquiring medication pressure difference data, wherein the medication pressure difference data is data used to represent the pressure difference in a closed area;
[0125] Determine whether the drug administration pressure difference data meets the preset drug administration pressure difference range;
[0126] If not, generating an updated temperature control parameter, wherein the updated temperature is determined according to the temperature control parameter until the medication pressure difference satisfies a preset medication pressure difference range;
[0127] If satisfied, administer the medication in a confined administration area.
[0128] In an embodiment of the present application, a pressure difference detection element provided in the drug delivery device is used to detect the pressure difference in the drug delivery area to detect whether the pressure difference in the drug delivery area meets a preset drug delivery pressure difference range. The preset drug delivery pressure difference range is, for example, when performing drug delivery treatment for kidney disease, the drug delivery pressure difference range at the drug delivery position corresponds to the treatment rule for kidney disease, and when performing drug delivery treatment for lung disease, the drug delivery pressure range at the drug delivery position corresponds to the treatment rule for lung disease. Within the above-mentioned drug delivery pressure difference range, the drug component penetrates the skin to reach the drug delivery site. When the detected drug delivery pressure difference does not meet the pressure difference data for the drug to penetrate the skin and enter the lesion, the drug delivery control parameters in the drug delivery device are controlled to change to achieve the effect of the drug penetrating the skin to reach the lesion for drug delivery treatment.
[0129] In another optional embodiment of the present application, a method for controlling temperature is also provided, which includes the following steps: detecting the temperature in the medication area by a temperature detection element provided in the medication device, and determining whether the detected temperature is within a preset temperature range; if the detected temperature does not meet the preset temperature range, the temperature control module adjusts the temperature in the closed medication area to avoid skin medication caused by high temperature in the medication area causing damage to the skin; and by adjusting the temperature within the preset temperature range, the pressure difference in the closed medication area is adjusted; through the feedback adjustment module, the pressure difference in the closed medication area is adjusted and controlled by temperature adjustment, and damage to the skin at the medication position during the medication process is avoided.
[0130] In another optional embodiment of the present application, a drug administration control method for skin drug administration is provided. When skin drug administration is performed, the first drug administration pressure in the direct drug administration unit is set to va, the second drug administration pressure in the auxiliary drug administration unit is set to vb, and the drug administration temperature of the direct drug administration unit is set to T. When controlling skin drug administration, a pressure difference ci is formed in the drug administration area. The expression for the relationship between the drug administration pressure difference and the first drug administration pressure, the second drug administration pressure and the drug administration temperature is ci = f(va, vb, T). When skin drug administration is performed, the drug administration pressure difference is determined by the first drug administration pressure, the second drug administration pressure and the drug administration temperature.
[0131] FIG4 is a flow chart of a drug delivery control method for skin drug delivery provided by the present application. As shown in FIG4 , the method includes the following steps:
[0132] One of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter. By cooperating with the pressure control parameter and the temperature control parameter, the pressure difference in the sealed medication area is controlled.
[0133] S401: Determine first control parameter change data;
[0134] The first control parameter change data is parameter change data for representing the first control parameter;
[0135] S402: Determine a parameter change of a second control parameter according to the first control parameter change data to obtain second control parameter change data.
[0136] When controlling the pressure differential within the sealed medication administration area, the pressure differential is controlled using a first control parameter and a second control parameter. The temperature control parameter and the pressure control parameter are coupled and controlled to jointly achieve control of the medication pressure differential. When adjusting the first and second control parameters, the first and second control parameters influence each other. Changes in the first control parameter determine changes in the second control parameter, controlling the pressure differential within the sealed medication administration area and achieving dynamic control of the pressure differential during the medication administration process.
[0137] FIG5 is a structural diagram of a drug delivery control device for skin drug delivery provided by the present application. As shown in FIG5 , the drug delivery control device includes:
[0138] a parameter determination module 51 for determining drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, a first of the first control parameter and the second control parameter being a pressure control parameter, and the other of the first control parameter and the second control parameter being a temperature control parameter;
[0139] The pressure difference module 52 is used to control the pressure difference of the drug delivery through the skin by using pressure control parameters and temperature control parameters. The pressure difference is the pressure difference of the drug delivery through the skin.
[0140] FIG6 is a structural diagram of another drug delivery control device for skin drug delivery provided by the present application. As shown in FIG6 , the device includes:
[0141] An identification module 61 is used to identify the pressure control parameter to obtain a first pressure control parameter and a second pressure control parameter;
[0142] A first pressure module 62 is used to control the auxiliary drug delivery unit to generate a first pressure according to a first pressure control parameter, wherein the first pressure is used to fix the drug delivery device to the skin and form a closed drug delivery area;
[0143] A second pressure module 63 is configured to control the direct drug delivery unit to generate a second pressure according to a second pressure control parameter, wherein the first drug delivery pressure is less than the second drug delivery pressure;
[0144] A temperature control module 64 is used to control the direct drug delivery unit to generate a drug delivery temperature according to the temperature control parameters;
[0145] The pressure difference drug administration module 65 is used to form a pressure difference for skin drug administration in a closed drug administration area according to the drug administration temperature, the first pressure and the second pressure.
[0146] In another optional embodiment of the present application, FIG7 and FIG8 are structural diagrams of a drug delivery device for transdermal drug delivery provided by the present application. The drug delivery device is controlled by pressure and temperature coupling to control the drug delivery in a non-invasive manner through the skin to achieve drug delivery therapy. The drug delivery device includes:
[0147] The pressure component and the temperature component control the pressure and temperature of the skin drug delivery to form a pressure difference for skin drug delivery, and the pressure difference is the pressure difference for drug delivery through the skin.
[0148] The drug delivery device includes an auxiliary drug delivery component 71 and a direct drug delivery component 72.
[0149] The pressure assembly includes a first pressure assembly and a second pressure assembly;
[0150] The auxiliary drug delivery component is provided with a first pressure component, which generates a first pressure, and the first pressure is a pressure used to fix the drug delivery device to the skin and form a closed drug delivery area;
[0151] The direct drug delivery component is provided with a second pressure component and a temperature component. The second pressure component generates a second pressure, and the temperature component controls the temperature in the closed drug delivery area. The first pressure, the second pressure and the temperature control the pressure difference for skin drug delivery in the closed drug delivery area. The pressure difference is the pressure difference for drug delivery through the skin.
[0152] The first pressure component can be an air suction device for absorbing the gas in the auxiliary drug delivery component to form a first pressure for fixing the drug delivery device to the skin. The second pressure component can be an inflation device for forming a second pressure in the direct drug delivery component. The direct drug delivery component and the skin form a closed drug delivery area. A heating module is provided in the direct drug delivery component for heating in the closed drug delivery area to form a pressure difference in the closed drug delivery area for allowing the drug components to penetrate the skin.
[0153] The specific manner of executing the operations of each unit in the above embodiment has been described in detail in the embodiment of the method, and will not be elaborated on here.
[0154] In summary, in the present application, the drug is administered non-invasively through the skin by coupling temperature and pressure to achieve drug administration therapy. By determining the drug administration control parameters for skin drug administration, the drug administration control parameters include pressure control parameters and temperature control parameters. The pressure difference of drug administration at the skin drug administration position is controlled by coupling the pressure control parameters and the temperature control parameters to form a pressure difference for drug administration through the skin. By setting the pressure and temperature to form a pressure difference at the skin drug administration position to form a non-invasive drug administration through the skin, the problem of low drug administration efficiency in the prior art is solved, and the technical effect of improving drug administration efficiency is achieved.
[0155] It should be noted that the steps shown in the flowcharts of the accompanying drawings can be executed in a computer system such as a set of computer-executable instructions, and that, although a logical order is shown in the flowcharts, in some cases, the steps shown or described can be executed in an order different from that shown here.
[0156] Obviously, those skilled in the art should understand that the above-mentioned units or steps of the present application can be implemented using a general-purpose computing device. They can be concentrated on a single computing device or distributed across a network composed of multiple computing devices. Alternatively, they can be implemented using program codes executable by the computing device, so that they can be stored in a storage device and executed by the computing device, or they can be made into individual integrated circuit modules, or multiple modules or steps can be made into a single integrated circuit module for implementation. Thus, the present application is not limited to any specific combination of hardware and software.
[0157] The above description is merely a preferred embodiment of the present application and is not intended to limit the present application. Various modifications and variations are possible for those skilled in the art. Any modifications, equivalent substitutions, or improvements made within the spirit and principles of the present application shall be included within the scope of protection of the present application.
Claims
1. A drug administration control method for skin drug administration, characterized in that: The coupling control of temperature and pressure is used to control the non-invasive penetration of drugs through the skin to achieve drug administration therapy. The drug administration control method includes: determining drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, one of the first control parameter and the second control parameter is a pressure control parameter, and the other of the first control parameter and the second control parameter is a temperature control parameter; and The pressure difference of the drug delivery through the skin is controlled by the pressure control parameter and the temperature control parameter, and the pressure difference is the pressure difference of the drug delivery through the skin.
2. The drug administration control method according to claim 1, characterized in that: The drug administration control method is applied to a drug administration device provided with an auxiliary drug administration unit and a direct drug administration unit, and the drug administration control method includes: Identifying the pressure control parameter to obtain a first pressure control parameter and a second pressure control parameter; controlling the auxiliary drug delivery unit to generate a first pressure according to the first pressure control parameter, wherein the first pressure is used to fix the drug delivery device to the skin and form a closed drug delivery area; controlling the direct drug delivery unit to generate a second pressure according to the second pressure control parameter, wherein the first pressure is less than the second pressure; and The direct drug delivery unit is controlled according to the temperature control parameter to generate a drug delivery temperature. The drug delivery temperature, the first pressure, and the second pressure form a pressure difference for skin drug delivery in the closed drug delivery area.
3. The drug administration control method according to claim 2, characterized in that: The drug administration temperature, the first pressure, and the second pressure form a pressure difference for skin drug administration in the closed drug administration area, which includes: Acquiring medication pressure difference data, wherein the medication pressure difference data is data used to represent the pressure difference in the enclosed medication area; Determine whether the drug administration pressure difference data meets the preset drug administration pressure difference range, If not, generating an updated pressure control parameter, wherein updating the first pressure data and updating the second pressure data are determined according to the updated pressure control parameter until the medication pressure difference data satisfies the preset medication pressure difference range; and If satisfied, the drug is administered in the enclosed administration area.
4. The drug administration control method according to claim 2, characterized in that: The drug administration temperature, the first pressure, and the second pressure form a pressure difference for skin drug administration in the closed drug administration area, which includes: Acquiring medication pressure difference data, wherein the medication pressure difference data is data used to represent the pressure difference in a closed area; Determine whether the drug administration pressure difference data meets the preset drug administration pressure difference range; If not, generating an updated temperature control parameter, wherein the updated temperature is determined according to the temperature control parameter until the medication pressure difference satisfies a preset medication pressure difference range; If satisfied, administer the medication in a confined administration area.
5. The drug administration control method according to claim 1, characterized in that: Drug delivery control parameters determined for transdermal drug delivery include: determining first control parameter change data, wherein the first control parameter change data is parameter change data for representing a first control parameter; and The parameter change of the second control parameter is determined according to the first control parameter change data to obtain second control parameter change data.
6. The drug administration control method according to claim 1, characterized in that: Drug delivery control parameters determined for transdermal drug delivery include: Determining drug administration characteristic data, wherein the drug administration characteristic data includes drug characteristic data and drug administration location characteristic data; matching a medication control model corresponding to the drug characteristic data and the medication location characteristic data in a preset medication database, wherein the medication control model is a model for representing changes in the first control parameter and the second control parameter during medication time; and Changes in the first control parameter and the second control parameter are determined according to a drug administration control model.
7. The drug administration control method according to claim 1, characterized in that: Controlling the pressure difference of skin drug delivery by the pressure control parameter and the temperature control parameter includes: The pressure difference for skin administration is determined based on the first pressure, the second pressure and the administration temperature, wherein the expression for the administration pressure difference is: ci = f(va, vb, T), wherein ci is the pressure difference, va is the first pressure in the direct administration unit, vb is the second pressure in the auxiliary administration unit, and T is the administration temperature of the direct administration unit.
8. The drug administration control method according to claim 1, characterized in that: The drug delivery device is provided with a temperature detection element for detecting the temperature in the drug delivery area to achieve control of matching drug delivery. The drug delivery control method includes: Obtain medication temperature detection data, wherein the medication temperature detection data is the temperature in the medication area. Degree data; The drug administration detection data is judged based on a preset temperature range, If the detected temperature does not meet the preset temperature range, a temperature control parameter is generated.
9. A drug delivery control device for skin drug delivery, characterized in that: The drug administration control device is used to control the drug to be administered through the skin non-invasively through temperature and pressure coupling control to achieve drug administration treatment. The drug administration control device includes: a parameter determination module, configured to determine drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, a first of the first control parameter and the second control parameter being a pressure control parameter, and the other of the first control parameter and the second control parameter being a temperature control parameter; and The pressure difference module is used to control the pressure difference of skin drug delivery through the pressure control parameter and the temperature control parameter, wherein the pressure difference is the pressure difference for drug delivery through the skin.
10. The drug administration control device according to claim 9, characterized in that: The drug administration control device is applied to a drug administration device provided with an auxiliary drug administration unit and a direct drug administration unit, and the drug administration control device comprises: an identification module, configured to identify the pressure control parameter to obtain a first pressure control parameter and a second pressure control parameter; a first pressure module, configured to control the auxiliary drug delivery unit to generate a first pressure according to the first pressure control parameter, wherein the first pressure is used to fix the drug delivery device to the skin and form a closed drug delivery area; a second pressure module, configured to control the direct drug delivery unit to generate a second pressure according to the second pressure control parameter, wherein the first pressure is less than the second pressure; a temperature control module, configured to control the direct drug delivery unit to generate a drug delivery temperature according to the temperature control parameter; and The pressure difference drug administration module is used to form a pressure difference for skin drug administration in the closed drug administration area according to the drug administration temperature, the first pressure and the second pressure.
11. The drug administration control device according to claim 10, characterized in that: The pressure differential drug delivery module includes: a pressure difference acquisition module, configured to acquire medication pressure difference data, wherein the medication pressure difference data is data representing the pressure difference within the enclosed medication area; The pressure difference judgment module is used to judge whether the drug administration pressure difference data meets the preset drug administration pressure difference range, If the pressure difference control module does not meet the requirements, it generates an updated pressure control parameter, wherein the first pressure data and the second pressure data are updated according to the updated pressure control parameter until the medication pressure difference data meets the preset medication pressure difference range; and If satisfied, the drug is administered in the enclosed administration area.
12. The drug administration control device according to claim 10, characterized in that: The pressure differential drug delivery module includes: a pressure difference acquisition module, configured to acquire medication pressure difference data, wherein the medication pressure difference data is data representing the pressure difference within the enclosed medication area; The pressure difference judgment module is used to judge whether the drug administration pressure difference data meets the preset drug administration pressure difference range, The temperature control module generates an updated temperature control parameter if the condition is not met, wherein the updated temperature is determined according to the temperature control parameter until the medication pressure difference meets the preset medication pressure difference range; If satisfied, administer the medication in a confined administration area.
13. The drug administration control device according to claim 9, characterized in that: The parameter determination module includes: a first control parameter module, configured to determine first control parameter change data, wherein the first control parameter change data is parameter change data representing the first control parameter; and The second control parameter module is configured to determine a parameter change of the second control parameter according to the first control parameter change data to obtain second control parameter change data.
14. The drug administration control device according to claim 9, characterized in that: The parameter determination module includes: a drug administration data acquisition module, configured to determine drug administration characteristic data, wherein the drug administration characteristic data includes drug characteristic data and drug administration location characteristic data; a model matching module, configured to match a medication control model corresponding to the drug characteristic data and the medication location characteristic data in a preset medication database, wherein the medication control model is a model for representing changes in the first control parameter and the second control parameter during medication time; and The drug administration parameter determination module is used to determine the changes of the first control parameter and the second control parameter according to the drug administration control model.
15. The drug administration control device according to claim 9, characterized in that: The pressure difference module determines the pressure difference of skin drug delivery according to the first pressure, the second pressure and the drug delivery temperature, wherein the expression of the drug delivery pressure difference is: ci = f (va, vb, T), wherein ci is the pressure difference, va is the first pressure in the direct drug delivery unit, vb is the second pressure in the auxiliary drug delivery unit, and T is the temperature of the direct drug delivery unit. The dosage temperature of the element.
16. The drug administration control device according to claim 9, characterized in that: The drug delivery device is provided with a temperature detection element for detecting the temperature in the drug delivery area to achieve control of matching drug delivery. The drug delivery control device includes: a medication temperature detection module, configured to obtain medication temperature detection data, wherein the medication temperature detection data is temperature data within the medication area; The drug administration temperature judgment module is used to judge the drug administration detection data based on a preset temperature range. The drug administration temperature control module generates a temperature control parameter if the detected temperature does not meet the preset temperature range.
17. A drug delivery device for skin drug delivery, characterized in that: The drug delivery device is fixed to the skin and includes: The pressure component and the temperature component control the pressure and temperature of the skin drug delivery to form a pressure difference for the skin drug delivery, and the pressure difference is the pressure difference for drug delivery through the skin.
18. The drug delivery device according to claim 17, wherein The drug delivery device comprises an auxiliary drug delivery component and a direct drug delivery component, wherein: The pressure assembly includes a first pressure assembly and a second pressure assembly; The auxiliary drug delivery component is provided with the first pressure component, which generates a first pressure, and the first pressure is a pressure used to fix the drug delivery device on the skin and form a closed drug delivery area; The direct drug delivery component is provided with the second pressure component and the temperature component. The second pressure component generates a second pressure. The temperature component controls the temperature in the closed drug delivery area. The first pressure, the second pressure and the temperature control the pressure difference for skin drug delivery in the closed drug delivery area. The pressure difference is the pressure difference for drug delivery through the skin.
19. The drug delivery device according to claim 17, wherein The drug delivery device further comprises a drug delivery control device, wherein the drug delivery control device comprises: a parameter determination module, configured to determine drug delivery control parameters for transdermal drug delivery, wherein the control parameters include a first control parameter and a second control parameter, a first of the first control parameter and the second control parameter being a pressure control parameter, and the other of the first control parameter and the second control parameter being a temperature control parameter; and A pressure difference module for administering drugs to the skin through the pressure control parameter and the temperature control parameter The pressure difference is controlled by the pressure difference, which is the pressure difference for penetrating the skin to administer the drug.
20. A computer-readable storage medium, characterized in that The computer-readable storage medium stores computer instructions, and the computer instructions are used to enable the computer to execute the drug delivery control method for skin drug delivery according to any one of claims 1 to 8.
